Anti-CCR4 antibodies and methods of use therefor

Details for Australian Patent Application No. 2004201168 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Ruffing, Nancy; Wu, Lijun; Andrew, David

Agent Davies Collison Cave

Pub. Number AU-A-2004201168

Parent 27266

Filing date 19 March 2004

Wipo publication date 22 April 2004

International Classifications

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 033/577 Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

C12N 005/20 Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

8 April 2004 Complete Application Filed

22 April 2004 Application Open to Public Inspection

  Published as AU-A-2004201168

7 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004201169-Modified biological material

2004201167-Identification System